Tag: Vigabatrin
Cipla’s InvaGen Pharmaceuticals recalls Vigabatrin over seal integrity concerns
InvaGen Pharmaceuticals Inc., a wholly-owned subsidiary of Cipla Limited, has announced a voluntary recall of one lot of Vigabatrin for Oral Solution, USP 500mg, to ... Read More
Cipla Limited’s subsidiary InvaGen Pharmaceuticals recalls Vigabatrin Oral Solution
In an important safety announcement, Cipla Limited revealed that its wholly-owned subsidiary, InvaGen Pharmaceuticals Inc., based in the USA, is conducting a voluntary recall of ... Read More
Zydus Lifesciences gets FDA final approval for Vigabatrin for Oral Solution
Zydus Lifesciences has bagged final approval for seizures drug Vigabatrin for Oral Solution USP, 500 mg from the US Food and Drug Administration (FDA). Vigabatrin ... Read More
Lupin gets FDA approval for Vigabatrin for Oral Solution USP, 500 mg
Lupin Limited said that it has secured approval for Vigabatrin for Oral Solution USP, 500 mg, an anti-epileptic drug, from the US Food and Drug ... Read More